Posted by Michael Wonder on 03 Aug 2023
China’s NMPA accepts and grants priority review designation to the new drug application for Luye Pharma’s rotigotine extended release microspheres
1 August 2023 - The drug is the world’s first innovative microsphere formulation for treating Parkinson’s disease.
Luye Pharma announced that the new drug application of its weekly dosed rotigotine extended release microspheres for injection for the treatment of Parkinson’s disease has been accepted and granted priority review by the Center for Drug Evaluation of China's National Medical Products Administration.
